Related references
Note: Only part of the references are listed.Disease-free and overall survival after neoadjuvant chemotherapy in breast cancer: breast-conserving surgery compared to mastectomy in a large single-centre cohort study
Janine M. Simons et al.
BREAST CANCER RESEARCH AND TREATMENT (2021)
Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis
Laura M. Spring et al.
CLINICAL CANCER RESEARCH (2020)
Association between background parenchymal enhancement and tumor response in patients with breast cancer receiving neoadjuvant chemotherapy
R. Rella et al.
DIAGNOSTIC AND INTERVENTIONAL IMAGING (2020)
Comparison of breast density assessment between human eye and automated software on digital and synthetic mammography: Impact on breast cancer risk
M. Le Boulc'h et al.
DIAGNOSTIC AND INTERVENTIONAL IMAGING (2020)
Interobserver agreement issues in radiology
M. Benchoufi et al.
DIAGNOSTIC AND INTERVENTIONAL IMAGING (2020)
The Association of Background Parenchymal Enhancement at Breast MRI with Breast Cancer: A Systematic Review and Meta-Analysis
Christopher M. Monioson et al.
RADIOLOGY (2019)
Artificial intelligence and breast screening: French Radiology Community position paper
I Thomassin-Naggara et al.
DIAGNOSTIC AND INTERVENTIONAL IMAGING (2019)
Quantitative background parenchymal enhancement to predict recurrence after neoadjuvant chemotherapy for breast cancer
Sebastien Moliere et al.
SCIENTIFIC REPORTS (2019)
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
Carsten Denkert et al.
LANCET ONCOLOGY (2018)
Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI
Janice S. Sung et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Breast MRI phenotype and background parenchymal enhancement may predict tumor response to neoadjuvant endocrine therapy
Talal Hilal et al.
BREAST JOURNAL (2018)
Background parenchymal enhancement in breast magnetic resonance imaging: A review of current evidences and future trends
R. Rella et al.
DIAGNOSTIC AND INTERVENTIONAL IMAGING (2018)
The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT) A Review of 20,000 Breast Cancer Patients in the National Cancer Data Base (NCDB)
Oluwadamilola M. Fayanju et al.
ANNALS OF SURGERY (2018)
Changes in background parenchymal enhancement in HER2-positive breast cancer before and after neoadjuvant chemotherapy Association with pathologic complete response
Jing-Min Dong et al.
MEDICINE (2018)
Breast Cancer Tissue Markers, Genomic Profiling, and Other Prognostic Factors: A Primer for Radiologists
Nikki Tirada et al.
RADIOGRAPHICS (2018)
Decreased background parenchymal enhancement of the contralateral breast after two cycles of neoadjuvant chemotherapy is associated with tumor response in HER2-positive breast cancer
Chao You et al.
ACTA RADIOLOGICA (2018)
Magnetic resonance imaging and molecular features associated with tumor- infiltrating lymphocytes in breast cancer
Jia Wu et al.
BREAST CANCER RESEARCH (2018)
Prognostic values of Ki-67 in neoadjuvant setting for breast cancer: a systematic review and meta-analysis
Lun Li et al.
FUTURE ONCOLOGY (2017)
Heterogeneous Enhancement Patterns of Tumor-adjacent Parenchyma at MR Imaging Are Associated with Dysregulated Signaling Pathways and Poor Survival in Breast Cancer
Jia Wu et al.
RADIOLOGY (2017)
Association Between Background Parenchymal Enhancement and Pathologic Complete Remission Throughout the Neoadjuvant Chemotherapy in Breast Cancer Patients
Chao You et al.
TRANSLATIONAL ONCOLOGY (2017)
Breast Cancer: Current Molecular Therapeutic Targets and New Players
Siddavaram Nagini
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2017)
Background parenchymal enhancement on breast MRI: association with recurrence-free survival in patients with newly diagnosed invasive breast cancer
Yaeji Lim et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Background parenchymal enhancement in breast MRI before and after neoadjuvant chemotherapy: correlation with tumour response
H. Preibsch et al.
EUROPEAN RADIOLOGY (2016)
Background Parenchymal Enhancement on Preoperative Magnetic Resonance Imaging Association With Recurrence-Free Survival in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
Ji Soo Choi et al.
MEDICINE (2016)
Effect of background parenchymal enhancement on breast cancer detection with magnetic resonance imaging
M. Telegrafo et al.
DIAGNOSTIC AND INTERVENTIONAL IMAGING (2016)
Effect of Menstrual Cycle Phase on Background Parenchymal Uptake at Molecular Breast Imaging
Carrie B. Hruska et al.
ACADEMIC RADIOLOGY (2015)
Association between Parenchymal Enhancement of the Contralateral Breast in Dynamic Contrast-enhanced MR Imaging and Outcome of Patients with Unilateral Invasive Breast Cancer
Bas H. M. van der Velden et al.
RADIOLOGY (2015)
Background Parenchymal Enhancement of the Contralateral Normal Breast: Association with Tumor Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
Jeon Hor Chen et al.
TRANSLATIONAL ONCOLOGY (2015)
Use of and Mortality After Bilateral Mastectomy Compared With Other Surgical Treatments for Breast Cancer in California, 1998-2011
Allison W. Kurian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
Patricia Cortazar et al.
LANCET (2014)
Biomarkers for the clinical management of breast cancer: International perspective
Neill Patani et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
MRI Enhancement in Stromal Tissue Surrounding Breast Tumors: Association with Recurrence Free Survival following Neoadjuvant Chemotherapy
Ella F. Jones et al.
PLOS ONE (2013)
Breast stromal enhancement on MRI is associated with response to neoadjuvant chemotherapy
Jona Hattangadi et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2008)
Share Paper
